Skip to main content
. 2015 Oct 26;16:869. doi: 10.1186/s12864-015-2102-3

Fig. 1.

Fig. 1

Categorical analysis of changes in gene expression based on lung disease severity categorized by % predicted DLCO (top) or % predicted FVC (bottom) for novel IIP candidate genes rhotekin 2 (RTKN2 - left), selectin E (SELE - middle), and peptidase inhibitor 15 (PI15 – right). Mild, moderate, and severe are defined as percent predicted DLCO (mild ≥65 %, moderate <65 % and >35 %, and severe ≤35 %), or FVC (mild ≥75 %, moderate <75 % and >40 %, and severe ≤40 %). p values for severe vs mild groups are shown in Table 2